Literature DB >> 23730821

Childhood cancer survivors' school (re)entry: Australian parents' perceptions.

J K McLoone1, C E Wakefield, R J Cohn.   

Abstract

Starting or returning to school after intense medical treatment can be academically and socially challenging for childhood cancer survivors. This study aimed to evaluate the school (re)entry experience of children who had recently completed cancer treatment. Forty-two semi-structured telephone interviews were conducted to explore parents' perceptions of their child's (re)entry to school after completing treatment (23 mothers, 19 fathers, parent mean age 39.5 years; child mean age 7.76 years). Interviews were analysed using the framework of Miles and Huberman and emergent themes were organised using QSR NVivo8. Parents closely monitored their child's school (re)entry and fostered close relationships with their child's teacher to ensure swift communication of concerns should they arise. The most commonly reported difficulty related to aspects of peer socialisation; survivors either displayed a limited understanding of social rules such as turn taking, or related more to older children or teachers relative to their peers. Additionally, parents placed a strong emphasis on their child's overall personal development, above academic achievement alone. Improved parent, clinician and teacher awareness of the importance of continued peer socialisation during the treatment period is recommended in order to limit the ongoing ramifications this may have on school (re)entry post-treatment completion.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23730821     DOI: 10.1111/ecc.12054

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  6 in total

1.  Reliability and Validity of the Polish Version of the Esophageal-Atresia-Quality-of-Life Questionnaires to Assess Condition-Specific Quality of Life in Children and Adolescents Born with Esophageal Atresia.

Authors:  Anna Rozensztrauch; Robert Śmigiel; Dariusz Patkowski; Sylwester Gerus; Magdalena Kłaniewska; Julia Hannah Quitmann; Michaela Dellenmark-Blom
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

2.  Telling the Story of Childhood Cancer-The Experience of Families After Treatment.

Authors:  Penelope J Slater
Journal:  J Patient Exp       Date:  2019-08-21

3.  Effects of a physical activity program from diagnosis on cardiorespiratory fitness in children with cancer: a national non-randomized controlled trial.

Authors:  Martin Kaj Fridh Nielsen; Jesper Frank Christensen; Thomas Leth Frandsen; Troels Thorsteinsson; Lars Bo Andersen; Karl Bang Christensen; Peder Skov Wehner; Henrik Hasle; Lis Ørgaard Adamsen; Kjeld Schmiegelow; Hanne Bækgaard Larsen
Journal:  BMC Med       Date:  2020-07-06       Impact factor: 8.775

4.  The Developmental Pathways of Preschool Children with Acute Lymphoblastic Leukemia: Communicative and Social Sequelae One Year after Treatment.

Authors:  Marta Tremolada; Livia Taverna; Sabrina Bonichini; Marta Pillon; Alessandra Biffi
Journal:  Children (Basel)       Date:  2019-08-13

5.  Korean parents' perceptions of the challenges and needs on school re-entry during or after childhood and adolescent cancer: a multi-institutional survey by Korean Society of Pediatric Hematology and Oncology.

Authors:  Jun Ah Lee; Jae Min Lee; Hyeon Jin Park; Meerim Park; Byung Kiu Park; Hee Young Ju; Ji Yoon Kim; Sang Kyu Park; Young Ho Lee; Ye Jee Shim; Heung Sik Kim; Kyung Duk Park; Yeon-Jung Lim; Hee Won Chueh; Ji Kyoung Park; Soon Ki Kim; Hyoung Soo Choi; Hyo Seop Ahn; Jeong Ok Hah; Hyoung Jin Kang; Hee Young Shin; Mee Jeong Lee
Journal:  Clin Exp Pediatr       Date:  2019-11-14

6.  "My son can not attend the school because 5 classmates are unvaccinated". On the question of compulsory vaccinations and the risk for immune-compromised children into the schools: the case of paediatric cancer patients.

Authors:  Silvana Acquafredda; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2018-11-05       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.